ConductScience.org, home

Paper28042471

Response to anti-PD1 therapy with nivolumab in metastatic sarcomas.

Paoluzzi L and 6 others. Clin Sarcoma Res, 2016. Cited by 173 papers, by iCite.

Cite this record

ConductScience Library. Response to anti-PD1 therapy with nivolumab in metastatic sarcomas. Papers, record 28042471. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28042471

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Response to anti-PD1 therapy with nivolumab in metastatic sarcomas.
PubMed
Journal
Clin Sarcoma Res
PubMed
Year
2016
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
173
iCite
Relative citation ratio, by iCite
6.03
iCite
Revised in PubMed
2022-04-08
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Paoluzzi LLhttps://orcid.org/0000-0002-2656-5224
2Cacavio AA
3Ghesani MM
4Karambelkar AA
5Rapkiewicz AA
6Weber JJ
7Rosen GG

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References15

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
125705114Analysis of the intratumoral adaptive immune response in well differentiated and dedifferentiated retroperitoneal liposarcoma.Sarcoma2015https://conductscience.org/library/papers/25705114PubMed
226330427New Strategies in Sarcoma: Linking Genomic and Immunotherapy Approaches to Molecular Subtype.Clin Cancer Res2015https://conductscience.org/library/papers/26330427PubMed
322595799Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial.Lancet2012https://conductscience.org/library/papers/22595799PubMed
425975445Immunotherapeutic approaches to sarcoma.Curr Treat Options Oncol2015https://conductscience.org/library/papers/25975445PubMed
527148906Contemporary Therapy for Advanced Soft-Tissue Sarcomas in Adults: A Review.JAMA Oncol2016https://conductscience.org/library/papers/27148906PubMed
624349382Tumor infiltrating PD1-positive lymphocytes and the expression of PD-L1 predict poor prognosis of soft tissue sarcomas.PLoS One2013https://conductscience.org/library/papers/24349382PubMed
724378391WHO classification of soft tissue tumours: an update based on the 2013 (4th) edition.Pathology2014https://conductscience.org/library/papers/24378391PubMed
819901961Discovery of molecular subtypes in leiomyosarcoma through integrative molecular profiling.Oncogene2010https://conductscience.org/library/papers/19901961PubMed
920601955Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy.Nat Genet2010https://conductscience.org/library/papers/20601955PubMed
1027312065Analysis of PD-L1, T-cell infiltrate and HLA expression in chondrosarcoma indicates potential for response to immunotherapy specifically in the dedifferentiated subtype.Mod Pathol2016https://conductscience.org/library/papers/27312065PubMed
1122573349Rapid angiogenesis onset after discontinuation of sunitinib treatment of renal cell carcinoma patients.Clin Cancer Res2012https://conductscience.org/library/papers/22573349PubMed
1226678880Importance of immunopharmacogenomics in cancer treatment: Patient selection and monitoring for immune checkpoint antibodies.Cancer Sci2016https://conductscience.org/library/papers/26678880PubMed
1326451318A systematic evaluation of abscopal responses following radiotherapy in patients with metastatic melanoma treated with ipilimumab.Oncoimmunology2015https://conductscience.org/library/papers/26451318PubMed
1426742998Cancer statistics, 2016.CA Cancer J Clin2016https://conductscience.org/library/papers/26742998PubMed
1525540867Prevalence of tumor-infiltrating lymphocytes and PD-L1 expression in the soft tissue sarcoma microenvironment.Hum Pathol2015https://conductscience.org/library/papers/25540867PubMed

Download CSV of references

Cited by131

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 173 citations.

PMIDTitleJournalYearIn PapersSource
42958422Tazemetostat combined PD-1 inhibitor achieving prolonged survival in primary proximal epithelioid sarcoma: a case report and review of the literature.J Med Case Rep2026https://conductscience.org/library/papers/42958422PubMed
42650028Epithelioid Sarcoma: A Review and Update.Cancers (Basel)2026https://conductscience.org/library/papers/42650028PubMed
42525308Dedifferentiated Chondrosarcoma: Current Advances and Future Perspectives.Curr Treat Options Oncol2026https://conductscience.org/library/papers/42525308PubMed
42322431Oncolytic virus with an immune stimulatory payload for osteosarcoma therapy.Cancer Immunol Immunother2026https://conductscience.org/library/papers/42322431PubMed
42172443The promise of immunotherapy in the treatment of sarcoma: A state-of-the-art review of practice changing research and future directions.Hum Vaccin Immunother2026https://conductscience.org/library/papers/42172443PubMed
42147185Immune modulatory oncolytic virus for osteosarcoma therapy.Res Sq2026https://conductscience.org/library/papers/42147185PubMed
41964900PEComas: current concepts in diagnosis, molecular pathways, and emerging treatments.Oncologist2026https://conductscience.org/library/papers/41964900PubMed
41960153Integrative Oncology Approach in Advanced Myxofibrosarcoma: A Case Report of Prolonged Survival with High-Dose Vitamin C and Viscum album.Case Rep Oncol2026https://conductscience.org/library/papers/41960153PubMed
41752158Integrated Immune and Molecular Profiling Identifies Prognostic Subgroups and Therapeutic Targets in Chondrosarcoma.Int J Mol Sci2026https://conductscience.org/library/papers/41752158PubMed
41630035A systematic review and meta-analysis of pazopanib efficacy and adverse effects in sarcomas.J Transl Med2026https://conductscience.org/library/papers/41630035PubMed
41609192
A Case Report of Promising Response to Combination Therapy With an Immune Checkpoint Inhibitor (Pembrolizumab) and Multi-Targeted Tyrosine Kinase Inhibitor (Pazopanib) in Metastatic De-Differentiated Chondrosarcoma.
Cancer Rep (Hoboken)2026https://conductscience.org/library/papers/41609192PubMed
41341391Spontaneous hepatic rupture: A catastrophic complication in a patient with primary splenic angiosarcoma and hepatic metastasis: case report and literature review.Front Oncol2025https://conductscience.org/library/papers/41341391PubMed
41294677Chemotherapy Strategies and Their Efficacy for Mesenchymal Chondrosarcoma.Curr Oncol2025https://conductscience.org/library/papers/41294677PubMed
41131073Cancer-associated fibroblasts promote tumor progression in fusion-positive rhabdomyosarcoma.Sci Rep2025https://conductscience.org/library/papers/41131073PubMed
40927310Immunotherapy and Targeted Therapies in Sarcoma: Proposed Synergy with Combination Treatment.J Immunother Precis Oncol2025https://conductscience.org/library/papers/40927310PubMed
40867318Advances in the Molecular Biology of Chondrosarcoma for Drug Discovery and Precision Medicine.Cancers (Basel)2025https://conductscience.org/library/papers/40867318PubMed
40465137Retroperitoneal Sarcoma (RPS): A Systematic Review.Curr Oncol Rep2025https://conductscience.org/library/papers/40465137PubMed
40304333Identification and Experimental Validation of Tumor Antigens and Hypoxia Subtypes of Osteosarcoma for Potential mRNA Vaccine Development.Curr Med Chem2026https://conductscience.org/library/papers/40304333PubMed
40184088CD274/PD-L1 copy number gained malignant peripheral nerve sheath tumor: A case report and literature review.Medicine (Baltimore)2025https://conductscience.org/library/papers/40184088PubMed
40117529Genomic Characterization of Chondrosarcoma Reveals Potential Therapeutic Targets.JCO Precis Oncol2025https://conductscience.org/library/papers/40117529PubMed

See all 131 cited byDownload CSV of cited by

Genes8

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28042471

GET https://conductscience.org/api/papers/v1/28042471/cited_by?page=2